BioArctic AB (BRCTF)
20.00
+6.34
(+46.45%)
USD |
OTCM |
Nov 14, 15:33
BioArctic Total Liabilities (Quarterly): 19.09M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 19.09M |
March 31, 2024 | 13.48M |
December 31, 2023 | 13.86M |
September 30, 2023 | 10.40M |
June 30, 2023 | 8.523M |
March 31, 2023 | 6.718M |
December 31, 2022 | 6.914M |
September 30, 2022 | 6.122M |
June 30, 2022 | 9.261M |
March 31, 2022 | 11.01M |
December 31, 2021 | 12.05M |
September 30, 2021 | 14.56M |
June 30, 2021 | 15.16M |
March 31, 2021 | 14.62M |
December 31, 2020 | 17.46M |
Date | Value |
---|---|
September 30, 2020 | 17.39M |
June 30, 2020 | 17.10M |
March 31, 2020 | 16.37M |
December 31, 2019 | 22.35M |
September 30, 2019 | 25.38M |
June 30, 2019 | 29.75M |
March 31, 2019 | 30.46M |
December 31, 2018 | 41.79M |
September 30, 2018 | 39.36M |
June 30, 2018 | 45.07M |
March 31, 2018 | 54.82M |
December 31, 2017 | 61.67M |
September 30, 2017 | 67.38M |
June 30, 2017 | 67.96M |
December 31, 2016 | 71.39M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.122M
Minimum
Sep 2022
22.35M
Maximum
Dec 2019
13.29M
Average
13.86M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
Abliva AB | 0.7797M |
Oncopeptides AB | 14.80M |
BioInvent International AB | 8.369M |
Hansa Biopharma AB | 125.03M |
Camurus AB | 45.05M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 106.66M |
Shareholders Equity (Quarterly) | 87.57M |
Current Ratio | 7.177 |